The effect of overexpression of cyclin D1 on the outcome of tamoxifen treatment is controversial: overexpression of cyclin D1 messenger RNA was found to be predictive of poor prognosis in lymph node positive, OR-α-positive breast cancer (Kenny et al, 1999), which would support the hypothesis raised above. This evidence concerns the gene CCND1 and breast carcinoma.